Compare Aptos (APT) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aptos vs Enzyme — how do they compare? Aptos trades at Rp10,038 (market cap Rp8,6T, Rp404,51M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Aptos is far larger — about 64116.9× Enzyme's market cap, and Aptos's supply is capped (857,4M / 2,1B APT (41%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Aptos for 33 Days and Enzyme for 29 Days on average.
| APT | MLN | |
|---|---|---|
Market Cap | Rp8,6T | Rp134,13M |
Volume (24h) | Rp404,51M | Rp104,56M |
Circulating Supply | 857,4M / 2,1B APT (41%) | 3,3M MLN |
Typical Hold Time | 33 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aptos (APT) is currently trading at Rp10,023 with a market cap of Rp8.6T, showing bearish technical signals across moving averages while oscillators remain neutral. The token is trading near its pivot point of Rp10,077 with key support at Rp9,820 and resistance at Rp10,260. With only 41% of the maximum 2.1M APT supply in circulation, tokenomics suggest gradual distribution over time.
Overall outlook remains cautious with bearish technical momentum despite oversold RSI conditions. Key opportunities include potential bounce from support levels, while major risks involve continued downward pressure and limited fundamental catalysts. Investors should monitor network adoption metrics and trading volume patterns closely.
Enzyme (MLN) shows limited market activity with a market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates a relatively short hold time of 29 days, suggesting active trading patterns. Current technical positioning requires updated price data for comprehensive analysis. Recent ecosystem developments appear limited based on available information.
Overall outlook remains cautious due to limited market data and ecosystem activity. Key opportunities include potential protocol upgrades and increased adoption, while major risks involve low liquidity and market volatility. Investors should monitor on-chain metrics and exchange listings for improved visibility.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Aptos
Aptos is a Layer 1 Proof-of-Stake (PoS) blockchain that utilizes Move, an innovative smart contract programming language based on Rust. It aims to drive mainstream adoption of web3 by enabling a robust ecosystem of decentralized applications (dApps) that address real-word user needs.
Read more on APT →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
